Newsroom

Press releases and announcements

Official announcements from ElixirTrials, Inc. For media inquiries, contact info@elixirtrials.com.

ElixirTrials Emerges from Stealth to Build the Infrastructure Needed to Bring Clinical Trials to Every Community

July 20, 2026 · Press release

ElixirTrials comes out of stealth to bring clinical-trial infrastructure to community hospitals, so patients can access tomorrow's treatments through clinical research where they live.

ElixirTrials

Trials belong
where patients live.

ElixirTrials operates as a network of site-centric clinical trial operations designed to expand clinical trial access to underserved and geographically distributed patient populations. All participating hospital sites undergo formal feasibility assessment, regulatory documentation review, and protocol-specific staff training prior to site initiation.

Data collection, patient safety monitoring, and adverse event reporting are conducted in accordance with 21 CFR Part 11 and applicable Good Clinical Practice standards. ElixirTrials maintains full audit trail capability across all site activities via the Cauldron platform.

ElixirTrials is an integrated research organization operating in compliance with ICH-GCP guidelines and applicable FDA and EMA regulations. All trial activities are conducted under institutional review board (IRB) oversight.

Cauldron is a proprietary clinical trial management platform developed by ElixirTrials Inc. Site partnerships are subject to executed master service agreements.

Newsroom

Privacy Policy

ElixirTrials

ElixirTrials

Trials belong
where patients live.

ElixirTrials operates as a network of site-centric clinical trial operations designed to expand clinical trial access to underserved and geographically distributed patient populations. All participating hospital sites undergo formal feasibility assessment, regulatory documentation review, and protocol-specific staff training prior to site initiation.

Data collection, patient safety monitoring, and adverse event reporting are conducted in accordance with 21 CFR Part 11 and applicable Good Clinical Practice standards. ElixirTrials maintains full audit trail capability across all site activities via the Cauldron platform.

ElixirTrials is an integrated research organization operating in compliance with ICH-GCP guidelines and applicable FDA and EMA regulations. All trial activities are conducted under institutional review board (IRB) oversight.

Cauldron is a proprietary clinical trial management platform developed by ElixirTrials Inc. Site partnerships are subject to executed master service agreements.

Newsroom

Privacy Policy